Metaescaline

Metaescaline‏‎ (also known as 3,4,5-trimethoxy-4-ethylphenethylamine) is a psychedelic and hallucinogenic drug, which is structurally related to mescaline. It was first synthesized by Alexander Shulgin, a renowned chemist and psychopharmacologist.

History

Metaescaline was first synthesized and documented by Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known And Loved). Shulgin's research has contributed significantly to the understanding of the pharmacology of phenethylamine derivatives.

Pharmacology

Metaescaline is a phenethylamine, but its pharmacological action is not fully understood. It is believed to act as a serotonin receptor agonist, similar to other psychedelic drugs. This means it binds to and activates certain serotonin receptors in the brain, which can lead to altered perceptions and hallucinations.

Effects

The effects of metaescaline can vary greatly depending on the dose, individual physiology, and set and setting. Common effects reported include visual hallucinations, enhanced colors, altered thought processes, and a sense of euphoria. Some users also report experiencing negative effects such as nausea, anxiety, and confusion.

Legal Status

The legal status of metaescaline varies by country. In the United States, it is not specifically listed as a controlled substance, but it could potentially be considered an analog of mescaline, which is a Schedule I drug under the Controlled Substances Act.

See Also

• Mescaline
• Phenethylamine
• Psychedelic drug
• Hallucinogen
• Alexander Shulgin
• PiHKAL

• 
  Metaescaline